FDA’s “Balanced Approach” To Opioids Extols Naloxone Auto-injector
This article was originally published in The Pink Sheet Daily
Executive Summary
Top government officials hold two briefings on FDA’s approval of a naloxone delivery device for reversal of opioid overdose as the agency faces continued criticism for approval of Zohydro XR.